{"id":"NCT01254019","sponsor":"GlaxoSmithKline","briefTitle":"A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy","officialTitle":"A Phase III, Randomized, Double Blind, Placebo-controlled Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12-02","primaryCompletion":"2013-06-28","completion":"2013-06-28","firstPosted":"2010-12-06","resultsPosted":"2019-01-28","lastUpdate":"2019-01-28"},"enrollment":186,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Muscular Dystrophies"],"interventions":[{"type":"DRUG","name":"GSK2402968 6mg/kg/week","otherNames":[]}],"arms":[{"label":"GSK2402968","type":"EXPERIMENTAL"},{"label":"Placebo","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether GSK2402968 is effective in the treatment of ambulant boys with Duchenne muscular dystrophy resulting from a mutation thought to be corrected by exon 51 skipping.","primaryOutcome":{"measure":"Change From Baseline in Muscle Function Using the 6 Minute Walking Distance (6MWD) Test Assessed at Week 48","timeFrame":"Baseline (Day 0) and Week 48","effectByArm":[{"arm":"Placebo","deltaMin":-52.65,"sd":10.423},{"arm":"GSK2402968 6mg/kg/Week","deltaMin":-42.32,"sd":7.378}],"pValues":[{"comp":"OG000 vs OG001","p":"0.415"}]},"eligibility":{"minAge":"5 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":8},"locations":{"siteCount":47,"countries":["Argentina","Belgium","Brazil","Canada","Chile","Czechia","Denmark","France","Germany","Hungary","Italy","Japan","Netherlands","Norway","Poland","Russia","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["29203355"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":61},"commonTop":["Injection site erythema","Nasopharyngitis","Proteinuria","Headache","Injection site discolouration"]}}